New prophylactic treatment

Colin Kerr

Posted: Thursday, April 1, 2021

Santen has announced the launch of Ducressa, a fixed-dose combination (FDC) of levofloxacin/ dexamethasone eye drops solution that is indicated for the prevention and treatment of inflammation, and the prevention of infection associated with cataract surgery in adults. “With the launch of this new FDC, many ophthalmologists now have a new approach in their practice to prevent infection in their cataract surgery patient,” said Prof Marc Coassin, University of Rome, Italy.